Cargando…

Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy

Detalles Bibliográficos
Autores principales:	Li, Songtao, Song, Zhenyuan, Yao, Ping, Qin, Jiangjiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889066/ https://www.ncbi.nlm.nih.gov/pubmed/35250600 http://dx.doi.org/10.3389/fphar.2022.848334

Ejemplares similares

Challenges in phytotherapy research
por: Panossian, Alexander
Publicado: (2023)

Neurotrophic basis to the pathogenesis of depression and phytotherapy
por: Wang, Huiqin, et al.
Publicado: (2023)

Editorial: Evolution of phytochemicals and phytotherapies in the treatment and management of cancer: targeted strategies in cancer precision medicine
por: Adnan, Mohd, et al.
Publicado: (2023)

Phytotherapy for Cachexia: Where Do We Stand?
por: Kuchta, Kenny, et al.
Publicado: (2020)

Editorial: Treatment of animal diseases with veterinary phytotherapy
por: Nabi, Fazul, et al.
Publicado: (2023)

Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review
por: Abdelgawad, Shimaa M., et al.
Publicado: (2022)

Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis
por: Dutta, Tusheema, et al.
Publicado: (2022)

Phytotherapies in inflammatory bowel disease
por: Ganji-Arjenaki, Mahboube, et al.
Publicado: (2019)

Editorial: Natural products as potential therapies for non-alcoholic fatty liver disease
por: Ibrahim, Islam A. A. E. H., et al.
Publicado: (2023)

Polypodium leucotomos targets multiple aspects of oral carcinogenesis and it is a potential antitumor phytotherapy against tongue cancer growth
por: Lacerda, Pammela A., et al.
Publicado: (2023)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
por: Blas-García, Ana, et al.
Publicado: (2022)

Comprehensive Analysis of the Expression Profiles of Hepatic lncRNAs in the Mouse Model of Alcoholic Liver Disease
por: Dou, Xiaobing, et al.
Publicado: (2021)

The Diseases of the Medici Family and the Use of Phytotherapy
por: Lippi, Donatella
Publicado: (2007)

Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis
por: Kositamongkol, Chayanis, et al.
Publicado: (2021)

INDIGENOUS PHYTOTHERAPY FOR FILARIASIS FROM ORISSA
por: Girach, R.D., et al.
Publicado: (1998)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
por: Pi, Aiwen, et al.
Publicado: (2021)

Phytotherapy in primary health care
por: Antonio, Gisele Damian, et al.
Publicado: (2014)

Phytotherapy of Skin Disease by Plants of Patalkot and Tamiya
por: Rai, M.K, et al.
Publicado: (1997)

Phytotherapy: emerging therapeutic option in urologic disease
por: Kim, Sae Woong
Publicado: (2012)

Phytotherapy in treatment of Parkinson’s disease: a review
por: Rabiei, Zahra, et al.
Publicado: (2019)

Editorial: Adolescent brain and alcohol
por: Pandey, Subhash C., et al.
Publicado: (2022)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions
por: Ore, Ayokanmi, et al.
Publicado: (2021)

Phytotherapy in the Management of Diabetes: A Review
por: Governa, Paolo, et al.
Publicado: (2018)

Phytotherapy and Nutritional Supplements on Breast Cancer
por: Lopes, C. M., et al.
Publicado: (2017)

Phytotherapy for the Treatment of Glioblastoma: A Review
por: Mian, Shan Yasin, et al.
Publicado: (2022)

Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Multi-Omics Reveals Inhibitory Effect of Baicalein on Non-Alcoholic Fatty Liver Disease in Mice
por: Li, Ping, et al.
Publicado: (2022)

Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy
por: Zhang, Li, et al.
Publicado: (2018)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Editorial: Sortilin and Sortilin Partners in Physiology and Pathologies
por: Mazella, Jean, et al.
Publicado: (2019)

Editorial: Peptidyl-Prolyl Isomerases in Human Pathologies
por: Tuccinardi, Tiziano, et al.
Publicado: (2019)

Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Wu, Jingyi, et al.
Publicado: (2023)

Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic Implications
por: Marfella, Raffaele, et al.
Publicado: (2022)

Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease
por: Fuenzalida, Catalina, et al.
Publicado: (2021)

Activation of AMP-Activated Protein Kinase-Sirtuin 1 Pathway Contributes to Salvianolic Acid A-Induced Browning of White Adipose Tissue in High-Fat Diet Fed Male Mice
por: Lai, Jianfei, et al.
Publicado: (2021)

Hepatic SIRT3 Upregulation in Response to Chronic Alcohol Consumption Contributes to Alcoholic Liver Disease in Mice
por: Ma, Yue, et al.
Publicado: (2019)

Editorial: Nonalcoholic fatty liver disease: From pathogenesis to phytomedicine based on omics technology
por: Ji, Guang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7bftve6mb2sc3bnl2aljcidcdf